Optiscan Imaging (OIL)

Shares / Stock Code

OIL

Stock Exchange / Sharemarket

Australian Securities Exchange

Optiscan Imaging (OIL) is a Melbourne-based, publicly listed Australian medical device company. The Optiscan Technology is a patented combination of optical fibre and laser technologies incorporated into miniaturised confocal microscopes. Optiscan's microscopes are small enough to fit inside the body and produce unique high magnification, high resolution, digital images of intact living tissue in real time for the detection of pathological changes. These images assist clinicians with identification of treatment options and enable improved patient outcomes. Optiscan has developed a range of products, charting a strategic progression from scientific laboratory instrument for ex-vivo analysis to miniaturised clinical tool for in-vivo Live Micro Imaging. The goal is to achieve commercialisation of breakthrough clinical diagnostic and imaging systems for use in a range of conditions including inflammatory bowel disease and cancer diagnosis.

Optiscan Imaging is a Melbourne-based company established in 1994 and listed on the Australian stockmarket (ASX) in August 1997. In 2001 the first human confocal endomicroscopy was completed and in 2002 OIL formed a joint venture with Pentax. In 2003 Pentax's flexible endomicroscope entered clinical trials. The endomicroscope comprises of a scope, confocal control box and a video processor unit.

Optiscan Imaging's microscopes are small enough to fit inside the body and produce high magnification, sharp, digital images of intact living tissue in real time for the detection of pathological changes in human tissue. By identifying these changes in-vivo, clinicians have more information from which to make recommendations on biopsy and treatment options.OIL's major customers include private and public hospitals, the general public, GPs and other health professionals. Major competitors are various other biotechnology companies distributing various medical products in the field of optics.Its subsidiaries include Optiscan Pty Ltd and Optiscan Inc.

Optiscan Imaging (OIL) Products and Services

  • The research and development of a High Magnification Endoscope for clincial diagnosis and research; and the continuation of sales of the research grade benchtop confocal microscope system within Australia.

Optiscan Imaging (OIL) Locations and Subsidiaries

Optiscan Imaging Head Office
15-17 Normanby Road, NOTTING HILL,
VIC, AUSTRALIA, 3168
Phone: 03 9538 3333
Fax: 03 9562 7742

Optiscan Imaging (OIL) Share Price

Submitted by ASX Listed Company on 15 May, 2010 - 18:33

Download our FREE App


Signup for Free
Don't miss out on your free share trading articles.


Free Risk Money Management Calculator for those who sign up!